Zhejiang Starry PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 2/6
Zhejiang Starry PharmaceuticalLtd has a total shareholder equity of CN¥1.8B and total debt of CN¥3.1B, which brings its debt-to-equity ratio to 176%. Its total assets and total liabilities are CN¥5.4B and CN¥3.6B respectively. Zhejiang Starry PharmaceuticalLtd's EBIT is CN¥203.8M making its interest coverage ratio 1.7. It has cash and short-term investments of CN¥523.0M.
Key information
176.0%
Debt to equity ratio
CN¥3.12b
Debt
| Interest coverage ratio | 1.7x |
| Cash | CN¥522.96m |
| Equity | CN¥1.77b |
| Total liabilities | CN¥3.58b |
| Total assets | CN¥5.35b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 603520's short term assets (CN¥2.1B) do not cover its short term liabilities (CN¥2.7B).
Long Term Liabilities: 603520's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥885.3M).
Debt to Equity History and Analysis
Debt Level: 603520's net debt to equity ratio (146.4%) is considered high.
Reducing Debt: 603520's debt to equity ratio has reduced from 202.7% to 176% over the past 5 years.
Debt Coverage: 603520's debt is not well covered by operating cash flow (5.7%).
Interest Coverage: 603520's interest payments on its debt are not well covered by EBIT (1.7x coverage).